Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Mar;7(3):707-10.
doi: 10.1002/j.1460-2075.1988.tb02866.x.

A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction

Affiliations

A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction

W H Moolenaar et al. EMBO J. 1988 Mar.

Abstract

The EGF-receptor (EGF-R) is a transmembrane glycoprotein with intrinsic protein tyrosine kinase (TK) activity. To explore the importance of the receptor TK in the action of EGF, we have used transfected NIH-3T3 cells expressing either the normal human EGF-R or a receptor mutated at Lys721, a key residue in the presumed ATP-binding region. The wild-type receptor responds to EGF by causing inositol phosphate formation, Ca2+ influx, activation of Na+/H+ exchange and DNA synthesis. In contrast, the TK-deficient mutant receptor fails to evoke any of these responses. It is concluded that activation of the receptor TK is a crucial signal that initiates the multiple post-receptor effects of EGF leading to DNA synthesis. Furthermore, the results suggest that tyrosine phosphorylation plays a role in the activation of the phosphoinositide signalling system.

PubMed Disclaimer

References

    1. Cell. 1979 Apr;16(4):777-85 - PubMed
    1. Mol Cell Biol. 1987 Dec;7(12):4568-71 - PubMed
    1. Biochemistry. 1981 Oct 13;20(21):6280-6 - PubMed
    1. J Biol Chem. 1983 Oct 25;258(20):12644-53 - PubMed
    1. J Biol Chem. 1985 Mar 25;260(6):3440-50 - PubMed

Publication types